RNA short interest
Atrium Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 3,395,873 |
|---|---|
| Change vs prior report | -1,918 (-0.1%) |
| Change over six months | +77.5% |
| Days to cover | 8.27 (sector: 3.78) |
| Average daily volume | 410,851 |
| Rank in Healthcare | #189 of 922 by days to cover |
RNA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 3,395,873 | -0.1% | 8.27 | 410,851 |
| 2026-09-15 | 3,397,791 | +1.4% | 8.15 | 417,130 |
| 2026-08-31 | 3,351,526 | -3.7% | 19.79 | 169,372 |
| 2026-08-14 | 3,480,849 | -0.9% | 27.46 | 126,745 |
| 2026-07-31 | 3,514,133 | -2.1% | 28.39 | 123,798 |
| 2026-07-15 | 3,591,224 | -1.8% | 17.71 | 202,748 |
| 2026-06-30 | 3,656,821 | +1.3% | 12.52 | 292,054 |
| 2026-06-15 | 3,610,418 | -1.2% | 20.31 | 177,756 |
| 2026-05-29 | 3,653,605 | -2.1% | 15.83 | 230,736 |
| 2026-05-15 | 3,732,204 | +8.9% | 21.18 | 176,203 |
| 2026-04-30 | 3,425,955 | +13.6% | 8.71 | 393,381 |
| 2026-04-15 | 3,016,880 | +57.6% | 6.00 | 502,487 |
| 2026-03-31 | 1,913,700 | +61.5% | 2.90 | 659,361 |
| 2026-03-13 | 1,184,615 | +173.7% | 1.00 | 1,401,988 |
| 2026-02-27 | 432,798 | +100.0% | 1.00 | 731,579 |
| 2026-02-13 | 10,156,722 | +16.1% | 3.56 | 2,853,751 |
| 2026-01-30 | 8,745,197 | +4.0% | 6.35 | 1,377,968 |
| 2026-01-15 | 8,406,349 | -4.4% | 4.20 | 1,999,340 |
| 2025-12-31 | 8,791,796 | -9.7% | 4.61 | 1,907,860 |
| 2025-12-15 | 9,740,063 | +9.9% | 4.12 | 2,363,887 |
| 2025-11-28 | 8,865,578 | -14.1% | 3.31 | 2,676,349 |
| 2025-11-14 | 10,321,719 | -1.7% | 2.03 | 5,092,006 |
| 2025-10-31 | 10,497,758 | -47.6% | 1.00 | 12,878,301 |
| 2025-10-15 | 20,028,193 | -3.5% | 13.50 | 1,483,734 |
| 2025-09-30 | 20,751,004 | -6.7% | 7.32 | 2,835,828 |
import finzdata as yf
yf.Ticker("RNA").short_interest # every report since 2017
yf.Client().short_interest(["RNA"], start="2018-01-01")Healthcare short interest · RNA price history · Who owns RNA · All short interest